We are monitoring the impact of COVID-19 on Nuclear Medicine Diagnostics Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 98
Share on
Share on

Global Nuclear Medicine Diagnostics Market Size, Share, Trends & Growth Analysis Report – Segmented By SPECT, Application & Region - Industry Forecast (2020 to 2025)

Pulished: February, 2020
ID: 98
Pages: 181

Nuclear Medicine Diagnostics Market Size (2020 to 2025)

The global Nuclear Medicine Diagnostics Market is estimated at USD 12.6 billion in 2020. It is forecasted to reach USD 23.42 billion by 2025, at a compound annual growth rate (CAGR) of 13.2%.

Nuclear medicine diagnosis involves using radioactive tracers to image and/or measure the overall or regional function of an organ. The radioactive tracer (radiopharmaceutical) is administered to the patient by intravenous injection, orally, or by other routes depending on the organ and the function to be studied. The absorption, turnover, and/or excretion of the tracer substance is then examined with a gamma camera, a positron emission tomography (PET) camera, or another instrument, such as a simple stationary radiation detector. Absorption of the tracer is usually a measure of organ function or organ metabolism, or blood flow.

Nuclear medicine is primarily concerned with the use of radioactive substances in research, diagnosis, and treatment. The increasing incidence of cancer and heart disease are the main drivers of the market studied. According to the National Cancer Institute (NCI) report, approximately 1,740,421 new cancer cases were diagnosed in the United States in 2019, where the adoption of nuclear medicine has increased. Regulatory requirements are another obstacle to translational research and clinical investigations. In the United States, all pharmacological agents, including diagnostic radiopharmaceuticals and radiotherapeutics, are subject to the FDA's regulatory oversight. Radiopharmaceuticals are subject to increased scrutiny and are subject to unique regulatory and approval pathways.

MARKET DRIVERS:

Several factors are expected to increase the demand for nuclear medicine, but none are more important than the increasing prevalence of cancer and heart disease. According to the World Health Organization (WHO), cancer causes almost one in six deaths worldwide. The population that suffers from it is continuously increasing due to the lifestyle that involves tobacco and alcohol, low consumption of fruits and vegetables, and lack of physical activity. The latest product released in radiopharmaceuticals and the strong and robust portfolio of many key market players is other critical factors. The rising call for nuclear imaging has led to the launch of the latest products and improved robust pipelines for diagnostic radiopharmaceuticals. Due to the high prevalence of cancer and the wide application of nuclear medicine imaging in its diagnosis, several product launches have targeted oncology applications.

MARKET RESTRAINTS:

Strict regulatory policies coupled with growing competition from conventional alternatives act as market restraints for nuclear medicine diagnostics' growth during the forecast period mentioned above. The high cost of equipment and diagnostics, which will become the biggest challenge for market growth.

Impact of COVID-19 on the global nuclear medicine diagnostics market 

The 2019 coronavirus pandemic (COVID-19) has posed significant challenges to health systems worldwide, whether in the preparedness, response, or recovery phase of the pandemic. It has been managed primarily by drastically reducing hospital and outpatient services for other illnesses and implementing infection prevention and control (IPC) measures. Positron Emission Tomography / Computed Tomography (PET / CT) scan decreased an average of 37%. In comparison, sentinel node procedures decreased by 47%, lung scans by 58%, bone scans by 62%, myocardial studies in 67%, and thyroid studies in 68%. Of all participating centers, 82% performed radionuclide therapy and reported a 46% reduction on average over the past four weeks, ranging from over 77% in Latin America and Southeast Asia to 17% in South Korea. South and Singapore. Survey results showed that 53% of participating sites limited their generator purchases to 99mTc / 99MB, and 13% of them temporarily canceled orders. Insufficient supply of essential materials (radioisotopes, generators, and kits) has been reported, especially for the 99mTc / 99Mo and 131I generators, especially in Africa, Asia, and Latin America. Nuclear medicine diagnostic procedures have plummeted, and the pandemic has hit countries around the world.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2019 to 2025

Base Year

2019

Forecast Period

2020 to 2025

Segments Covered

By Type, Application and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This research report on the global nuclear medicine diagnostics market has been segmented and sub-segmented based on the type, application, and region.

Nuclear Medicine Diagnostics Market - By Type:

  • SPECT        
    • Technetium-99m
    • Thallium-201
    • Gallium-67
    • Iodine-23
    • Others
  • PET             
    • Fluorine-18
    • Rubidium-82
    • Others

Based on type, the segment of F-18 represented the largest share of the PET radiopharmaceuticals nuclear medicine market. Because of its lower half-life (110 minutes) relative to other radioisotopes, F-18 is the most widely used PET radioisotope. It is projected that F-18 accounts for 98% of the total market for PET radioisotopes.

Nuclear Medicine Diagnostics Market - By Application:

  • Cardiology               
    • Lymphoma             
    • Thyroid     
    • Neurology
    • Oncology 
    • Others  

Based on the application, the oncology segment is expected to show the highest growth rate over the forecast period. Radiotherapy could be used to treat different medical conditions, especially cancer, by using radiation to weaken or kill specifically targeted cells. PET, which is an accurate technique, uses cyclotron-made isotopes. It is widely used in oncology for a medical function, with fluorine-18 as the tracer, and is known to be the most effective non-invasive method of detecting and assessing most cancers.

Nuclear Medicine Diagnostics Market - By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa

Regionally, North America held the largest market share in the radioisotope industry for nuclear medicine. The United States is North America's largest contributor to sales and is expected to maintain its dominance due to the increased number of procedures and increased use of nuclear medicine isotopes for different therapeutic applications. Canada is Technetium-99 m's largest manufacturer. The market is likely to expand at a tremendous pace in Canada because of the use of Tc-99 m in radiopharmaceuticals. In various diagnostic procedures and treatments, 80% of the nuclear medicine market is driven by Tc-99 m. The North American market is likely to witness increased growth rates and market dominance, taking into account these factors associated with the United States and Canada.

TOP COMPANIES IN THE MARKET PROFILED IN THIS REPORT

Promising companies operating in the Global Nuclear Medicine Diagnostics Market are Cardinal Health, Inc.Bracco Imaging S.p.AGE HealthcareEczacibasi-Monrol Nuclear ProductsNordion, Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc., Advanced Accelerator Applications S.A., IBA Molecular Imaging, Mallinckrodt PLC.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Analysis Design                         

                2.3 Research Phases                      

                                2.3.1 Secondary Research            

                                2.3.2 Primary Research 

                                2.3.3 Econometric Modelling     

                                2.3.4 Expert Validation  

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Type                        

                                5.1.1 SPECT        

                                                5.1.1.1 Technetium-99m

                                                5.1.1.2 Thallium-201

                                                5.1.1.3 Gallium-67

                                                5.1.1.4 Iodine-23

                                                5.1.1.5 Others

                                5.1.2 PET             

                                                5.1.2.1 Fluorine-18

                                                5.1.2.2 Rubidium-82

                                                5.1.2.3 Others

                5.2 By Application                           

                                5.2.1 Cardiology               

                                5.2.2 Lymphoma             

                                5.2.3 Thyroid     

                                5.2.4 Neurology

                                5.2.5 Oncology 

                                5.2.6 Others      

6. Geographical Analysis                                              

                6.1 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.2 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy           

                                6.2.6 France      

                6.3 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan        

                                6.3.5 South Korea           

                6.4 Latin America                            

                                6.4.1 Introduction           

                                6.4.2 Brazil         

                                6.4.3 Argentina

                                6.4.4 Mexico     

                6.5 Middle East & Africa               

                                6.5.1 UAE           

                                6.5.2 Saudi Arabia           

                                6.5.3 Israel         

                                6.5.4 South Africa            

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 GE Healthcare                           

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues            

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Cardinal Health Inc.                 

                8.3 Bracco Imaging S.p.A                              

                8.4 Eczacibasi-Monrol Nuclear Products                

                8.5 Nordion, Inc.                              

                8.6 Bayer Healthcare                     

                8.7 Lantheus Medical Imaging, Inc.                          

                8.8 Advanced Accelerator Applications S.A.                         

                8.9 IBA Molecular Imaging                           

                8.10 Mallinckrodt plc.                    

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Expert Opinions                                         

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Nuclear Medicine Diagnostics Market, By Region, From 2020 to 2025 (USD Billion)
  2. Global Nuclear Medicine Diagnostics Market, By Type, From 2020 to 2025 (USD Billion)
  3. Global SPECT Diagnostic Radioisotopes Market, By Region, From 2020 to 2025 (USD Billion)
  4. Global PET Diagnostic Radioisotopes Market, By Region, From 2020 to 2025 (USD Billion)
  5. Global Nuclear Medicine Diagnostics Market, By Application, From 2020 to 2025 (USD Billion)
  6. Global Cardiology Market, By Region, From 2020 to 2025 (USD Billion)
  7. Global Lymphoma Market, By Region, From 2020 to 2025 (USD Billion)
  8. Global Thyroid Market, By Region, From 2020 to 2025 (USD Billion)
  9. Global Neurology Market, By Region, From 2020 to 2025 (USD Billion)
  10. Global Oncology Market, By Region, From 2020 to 2025 (USD Billion)
  11. Global Other Applications Market, By Region, From 2020 to 2025 (USD Billion)
  12. Global SPECT Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  13. Global Technetium-99m Market, By Region, From 2020 to 2025 (USD Billion)
  14. Global Thallium-201 Market, By Region, From 2020 to 2025 (USD Billion)
  15. Global Gallium-67 Market, By Region, From 2020 to 2025 (USD Billion)
  16. Global Iodine-23 Market, By Region, From 2020 to 2025 (USD Billion)
  17. Global Other SPECT Diagnostic Radioisotopes Market, By Region, From 2020 to 2025 (USD Billion)
  18. Global PET Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  19. Global Fluorine-18 Market, By Region, From 2020 to 2025 (USD Billion)
  20. Global Rubidium-82 Market, By Region, From 2020 to 2025 (USD Billion)
  21. Global Other PET Diagnostic Radioisotopes Market, By Region, From 2020 to 2025 (USD Billion)
  22. North America Nuclear Medicine Diagnostics Market, By Region, From 2020 to 2025 (USD Billion)
  23. North America Nuclear Medicine Diagnostics Market, By Type, From 2020 to 2025 (USD Billion)
  24. North America SPECT Diagnostic Radioisotopes Market, By Region, From 2020 to 2025 (USD Billion)
  25. North America PET Diagnostic Radioisotopes Market, By Region, From 2020 to 2025 (USD Billion)
  26. North America Nuclear Medicine Diagnostics Market, By Application, From 2020 to 2025 (USD Billion)
  27. North America Cardiology Market, By Region, From 2020 to 2025 (USD Billion)
  28. North America Lymphoma Market, By Region, From 2020 to 2025 (USD Billion)
  29. North America Thyroid Market, By Region, From 2020 to 2025 (USD Billion)
  30. North America Neurology Market, By Region, From 2020 to 2025 (USD Billion)
  31. North America Oncology Market, By Region, From 2020 to 2025 (USD Billion)
  32. North America Other Applications Market, By Region, From 2020 to 2025 (USD Billion)
  33. North America SPECT Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  34. North America Technetium-99m Market, By Region, From 2020 to 2025 (USD Billion)
  35. North America Thallium-201 Market, By Region, From 2020 to 2025 (USD Billion)
  36. North America Gallium-67 Market, By Region, From 2020 to 2025 (USD Billion)
  37. North America Iodine-23 Market, By Region, From 2020 to 2025 (USD Billion)
  38. North America Other SPECT Diagnostic Radioisotopes Market, By Region, From 2020 to 2025 (USD Billion)
  39. North America PET Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  40. North America Fluorine-18 Market, By Region, From 2020 to 2025 (USD Billion)
  41. North America Rubidium-82 Market, By Region, From 2020 to 2025 (USD Billion)
  42. North America Other PET Diagnostic Radioisotopes Market, By Region, From 2020 to 2025 (USD Billion)
  43. United States Nuclear Medicine Diagnostics Market, By Type, From 2020 to 2025 (USD Billion)
  44. United States Nuclear Medicine Diagnostics Market, By Application, From 2020 to 2025 (USD Billion)
  45. Canada Nuclear Medicine Diagnostics Market, By Type, From 2020 to 2025 (USD Billion)
  46. Canada Nuclear Medicine Diagnostics Market, By Application, From 2020 to 2025 (USD Billion)
  47. United States SPECT Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  48. Canada SPECT Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  49. United States PET Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  50. Canada PET Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  51. Europe Nuclear Medicine Diagnostics Market, By Region, From 2020 to 2025 (USD Billion)
  52. Europe Nuclear Medicine Diagnostics Market, By Type, From 2020 to 2025 (USD Billion)
  53. Europe SPECT Diagnostic Radioisotopes Market, By Region, From 2020 to 2025 (USD Billion)
  54. Europe PET Diagnostic Radioisotopes Market, By Region, From 2020 to 2025 (USD Billion)
  55. Europe Nuclear Medicine Diagnostics Market, By Application, From 2020 to 2025 (USD Billion)
  56. Europe Cardiology Market, By Region, From 2020 to 2025 (USD Billion)
  57. Europe Lymphoma Market, By Region, From 2020 to 2025 (USD Billion)
  58. Europe Thyroid Market, By Region, From 2020 to 2025 (USD Billion)
  59. Europe Neurology Market, By Region, From 2020 to 2025 (USD Billion)
  60. Europe Oncology Market, By Region, From 2020 to 2025 (USD Billion)
  61. Europe Other Applications Market, By Region, From 2020 to 2025 (USD Billion)
  62. Europe SPECT Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  63. Europe Technetium-99m Market, By Region, From 2020 to 2025 (USD Billion)
  64. Europe Thallium-201 Market, By Region, From 2020 to 2025 (USD Billion)
  65. Europe Gallium-67 Market, By Region, From 2020 to 2025 (USD Billion)
  66. Europe Iodine-23 Market, By Region, From 2020 to 2025 (USD Billion)
  67. Europe Other SPECT Diagnostic Radioisotopes Market, By Region, From 2020 to 2025 (USD Billion)
  68. Europe PET Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  69. Europe Fluorine-18 Market, By Region, From 2020 to 2025 (USD Billion)
  70. Europe Rubidium-82 Market, By Region, From 2020 to 2025 (USD Billion)
  71. Europe Other PET Diagnostic Radioisotopes Market, By Region, From 2020 to 2025 (USD Billion)
  72. U.K Nuclear Medicine Diagnostics Market, By Type, From 2020 to 2025 (USD Billion)
  73. U.K Nuclear Medicine Diagnostics Market, By Application, From 2020 to 2025 (USD Billion)
  74. Spain Nuclear Medicine Diagnostics Market, By Type, From 2020 to 2025 (USD Billion)
  75. Spain Nuclear Medicine Diagnostics Market, By Application, From 2020 to 2025 (USD Billion)
  76. Germany Nuclear Medicine Diagnostics Market, By Type, From 2020 to 2025 (USD Billion)
  77. Germany Nuclear Medicine Diagnostics Market, By Application, From 2020 to 2025 (USD Billion)
  78. Italy  Nuclear Medicine Diagnostics Market, By Type, From 2020 to 2025 (USD Billion)
  79. Italy  Nuclear Medicine Diagnostics Market, By Application, From 2020 to 2025 (USD Billion)
  80. France Nuclear Medicine Diagnostics Market, By Type, From 2020 to 2025 (USD Billion)
  81. France Nuclear Medicine Diagnostics Market, By Application, From 2020 to 2025 (USD Billion)
  82. U.K SPECT Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  83. Spain SPECT Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  84. Germany SPECT Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  85. Italy  SPECT Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  86. France SPECT Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  87. U.K PET Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  88. Spain PET Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  89. Germany PET Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  90. Italy  PET Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  91. France PET Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  92. Asia-Pacific Nuclear Medicine Diagnostics Market, By Region, From 2020 to 2025 (USD Billion)
  93. Asia-Pacific Nuclear Medicine Diagnostics Market, By Type, From 2020 to 2025 (USD Billion)
  94. Asia-Pacific SPECT Diagnostic Radioisotopes Market, By Region, From 2020 to 2025 (USD Billion)
  95. Asia-Pacific PET Diagnostic Radioisotopes Market, By Region, From 2020 to 2025 (USD Billion)
  96. Asia-Pacific Nuclear Medicine Diagnostics Market, By Application, From 2020 to 2025 (USD Billion)
  97. Asia-Pacific Cardiology Market, By Region, From 2020 to 2025 (USD Billion)
  98. Asia-Pacific Lymphoma Market, By Region, From 2020 to 2025 (USD Billion)
  99. Asia-Pacific Thyroid Market, By Region, From 2020 to 2025 (USD Billion)
  100. Asia-Pacific Neurology Market, By Region, From 2020 to 2025 (USD Billion)
  101. Asia-Pacific Oncology Market, By Region, From 2020 to 2025 (USD Billion)
  102. Asia-Pacific Other Applications Market, By Region, From 2020 to 2025 (USD Billion)
  103. Asia-Pacific SPECT Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  104. Asia-Pacific Technetium-99m Market, By Region, From 2020 to 2025 (USD Billion)
  105. Asia-Pacific Thallium-201 Market, By Region, From 2020 to 2025 (USD Billion)
  106. Asia-Pacific Gallium-67 Market, By Region, From 2020 to 2025 (USD Billion)
  107. Asia-Pacific Iodine-23 Market, By Region, From 2020 to 2025 (USD Billion)
  108. Asia-Pacific Other SPECT Diagnostic Radioisotopes Market, By Region, From 2020 to 2025 (USD Billion)
  109. Asia-Pacific PET Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  110. Asia-Pacific Fluorine-18 Market, By Region, From 2020 to 2025 (USD Billion)
  111. Asia-Pacific Rubidium-82 Market, By Region, From 2020 to 2025 (USD Billion)
  112. Asia-Pacific Other PET Diagnostic Radioisotopes Market, By Region, From 2020 to 2025 (USD Billion)
  113. China Nuclear Medicine Diagnostics Market, By Type, From 2020 to 2025 (USD Billion)
  114. China Nuclear Medicine Diagnostics Market, By Application, From 2020 to 2025 (USD Billion)
  115. India Nuclear Medicine Diagnostics Market, By Type, From 2020 to 2025 (USD Billion)
  116. India Nuclear Medicine Diagnostics Market, By Application, From 2020 to 2025 (USD Billion)
  117. Japan Nuclear Medicine Diagnostics Market, By Type, From 2020 to 2025 (USD Billion)
  118. Japan Nuclear Medicine Diagnostics Market, By Application, From 2020 to 2025 (USD Billion)
  119. South Korea Nuclear Medicine Diagnostics Market, By Type, From 2020 to 2025 (USD Billion)
  120. South Korea Nuclear Medicine Diagnostics Market, By Application, From 2020 to 2025 (USD Billion)
  121. China SPECT Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  122. India SPECT Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  123. Japan SPECT Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  124. South Korea SPECT Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  125. China PET Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  126. India PET Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  127. Japan PET Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  128. South Korea PET Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  129. Latin America Nuclear Medicine Diagnostics Market, By Region, From 2020 to 2025 (USD Billion)
  130. Latin America Nuclear Medicine Diagnostics Market, By Type, From 2020 to 2025 (USD Billion)
  131. Latin America SPECT Diagnostic Radioisotopes Market, By Region, From 2020 to 2025 (USD Billion)
  132. Latin America PET Diagnostic Radioisotopes Market, By Region, From 2020 to 2025 (USD Billion)
  133. Latin America Nuclear Medicine Diagnostics Market, By Application, From 2020 to 2025 (USD Billion)
  134. Latin America Cardiology Market, By Region, From 2020 to 2025 (USD Billion)
  135. Latin America Lymphoma Market, By Region, From 2020 to 2025 (USD Billion)
  136. Latin America Thyroid Market, By Region, From 2020 to 2025 (USD Billion)
  137. Latin America Neurology Market, By Region, From 2020 to 2025 (USD Billion)
  138. Latin America Oncology Market, By Region, From 2020 to 2025 (USD Billion)
  139. Latin America Other Applications Market, By Region, From 2020 to 2025 (USD Billion)
  140. Latin America SPECT Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  141. Latin America Technetium-99m Market, By Region, From 2020 to 2025 (USD Billion)
  142. Latin America Thallium-201 Market, By Region, From 2020 to 2025 (USD Billion)
  143. Latin America Gallium-67 Market, By Region, From 2020 to 2025 (USD Billion)
  144. Latin America Iodine-23 Market, By Region, From 2020 to 2025 (USD Billion)
  145. Latin America Other SPECT Diagnostic Radioisotopes Market, By Region, From 2020 to 2025 (USD Billion)
  146. Latin America PET Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  147. Latin America Fluorine-18 Market, By Region, From 2020 to 2025 (USD Billion)
  148. Latin America Rubidium-82 Market, By Region, From 2020 to 2025 (USD Billion)
  149. Latin America Other PET Diagnostic Radioisotopes Market, By Region, From 2020 to 2025 (USD Billion)
  150. Brazil Nuclear Medicine Diagnostics Market, By Type, From 2020 to 2025 (USD Billion)
  151. Brazil Nuclear Medicine Diagnostics Market, By Application, From 2020 to 2025 (USD Billion)
  152. Mexico Nuclear Medicine Diagnostics Market, By Type, From 2020 to 2025 (USD Billion)
  153. Mexico Nuclear Medicine Diagnostics Market, By Application, From 2020 to 2025 (USD Billion)
  154. Argentina Nuclear Medicine Diagnostics Market, By Type, From 2020 to 2025 (USD Billion)
  155. Argentina Nuclear Medicine Diagnostics Market, By Application, From 2020 to 2025 (USD Billion)
  156. Brazil SPECT Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  157. Mexico SPECT Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  158. Argentina SPECT Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  159. Brazil PET Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  160. Mexico PET Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  161. Argentina PET Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  162. Middle East & Africa Nuclear Medicine Diagnostics Market, By Region, From 2020 to 2025 (USD Billion)
  163. Middle East & Africa Nuclear Medicine Diagnostics Market, By Type, From 2020 to 2025 (USD Billion)
  164. Middle East & Africa SPECT Diagnostic Radioisotopes Market, By Region, From 2020 to 2025 (USD Billion)
  165. Middle East & Africa PET Diagnostic Radioisotopes Market, By Region, From 2020 to 2025 (USD Billion)
  166. Middle East & Africa Nuclear Medicine Diagnostics Market, By Application, From 2020 to 2025 (USD Billion)
  167. Middle East & Africa Cardiology Market, By Region, From 2020 to 2025 (USD Billion)
  168. Middle East & Africa Lymphoma Market, By Region, From 2020 to 2025 (USD Billion)
  169. Middle East & Africa Thyroid Market, By Region, From 2020 to 2025 (USD Billion)
  170. Middle East & Africa Neurology Market, By Region, From 2020 to 2025 (USD Billion)
  171. Middle East & Africa Oncology Market, By Region, From 2020 to 2025 (USD Billion)
  172. Middle East & Africa Other Applications Market, By Region, From 2020 to 2025 (USD Billion)
  173. Middle East & Africa SPECT Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  174. Middle East & Africa Technetium-99m Market, By Region, From 2020 to 2025 (USD Billion)
  175. Middle East & Africa Thallium-201 Market, By Region, From 2020 to 2025 (USD Billion)
  176. Middle East & Africa Gallium-67 Market, By Region, From 2020 to 2025 (USD Billion)
  177. Middle East & Africa Iodine-23 Market, By Region, From 2020 to 2025 (USD Billion)
  178. Middle East & Africa Other SPECT Diagnostic Radioisotopes Market, By Region, From 2020 to 2025 (USD Billion)
  179. Middle East & Africa PET Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  180. Middle East & Africa Fluorine-18 Market, By Region, From 2020 to 2025 (USD Billion)
  181. Middle East & Africa Rubidium-82 Market, By Region, From 2020 to 2025 (USD Billion)
  182. Middle East & Africa Other PET Diagnostic Radioisotopes Market, By Region, From 2020 to 2025 (USD Billion)
  183. UAE Nuclear Medicine Diagnostics Market, By Type, From 2020 to 2025 (USD Billion)
  184. UAE Nuclear Medicine Diagnostics Market, By Application, From 2020 to 2025 (USD Billion)
  185. Saudi Arabia Nuclear Medicine Diagnostics Market, By Type, From 2020 to 2025 (USD Billion)
  186. Saudi Arabia Nuclear Medicine Diagnostics Market, By Application, From 2020 to 2025 (USD Billion)
  187. Israel Nuclear Medicine Diagnostics Market, By Type, From 2020 to 2025 (USD Billion)
  188. Israel Nuclear Medicine Diagnostics Market, By Application, From 2020 to 2025 (USD Billion)
  189. South Africa Nuclear Medicine Diagnostics Market, By Type, From 2020 to 2025 (USD Billion)
  190. South Africa Nuclear Medicine Diagnostics Market, By Application, From 2020 to 2025 (USD Billion)
  191. UAE SPECT Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  192. Saudi Arabia SPECT Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  193. Israel SPECT Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  194. South Africa SPECT Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  195. UAE PET Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  196. Saudi Arabia PET Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  197. Israel PET Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)
  198. South Africa PET Diagnostic Radioisotopes Market, By Type, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample